跳至主要内容
临床试验/EUCTR2016-000939-41-NO
EUCTR2016-000939-41-NO进行中(未招募)1 期

Diagnostic assessment of 18F-fluciclovine (FACBC) - PET/MRI in the evaluation of suspected cerebral gliomas

Anna Karlberg0 个研究点开始时间: 2016年3月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with suspicion of glioma will be included from the Department of Neurosurgery at St. Olavs Hospital. Due to the high cost of the PET tracer, this project will be limited to pre-operative low-and high grade adult glioma patients. Inclusion will start in April 2016 and end in December 2017, and we expect to reach 30 patients by the end of 2017.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 3
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 7

排除标准

  • Exclusion criteria will be general contra-indications for PET/MRI, and no ability to obtain informed consent (e.g. due to severe dysphasia or cognitive deficits).

研究者

发起方
Anna Karlberg

相似试验